DR. DAVID WOLFF GOLDFARB MD NPI 1225265168

NPI Details

DR. David Wolff Goldfarb, MD is an urology in Houston, TX with 19 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. David Wolff Goldfarb, MD NPI is 1225265168. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: BAYLOR COLLEGE OF MEDICINE
Graduation Year:2007

The provider's business location address is:

6560 FANNIN ST STE 1440
HOUSTON, TX
ZIP 77030-713
Phone: (713) 790-9700
Fax: (713) 790-1328

The NPI 1225265168 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Automated urinalysis test (HCPCS:81003)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Biopsy of prostate gland (HCPCS:55700)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Waterjet destruction of prostrate accessed through the urethra (HCPCS:0421T)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Injection procedure to cause erection (HCPCS:54235)
• Injection, testosterone enanthate, 1 mg (HCPCS:J3121)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 6/18/2009 and was last updated on 6/4/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: